Article Information
PubMed
Published By
History
- Received August 31, 2021
- Revision received May 27, 2022
- Accepted June 1, 2022
- Published online June 13, 2022.
Copyright & Usage
Copyright © 2022 Gannon et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
- Mary Gannon1,
- Bing Wang1,
- Sara Anne Stringfellow1,2,
- Stephan Quintin1,3,
- Itzel Mendoza1,
- Thanushri Srikantha1,
- A. Claire Roberts1,
- Takashi Saito4,5,
- Takaomi C. Saido4,
- Erik D. Roberson1 and
- Talene A. Yacoubian1
- 1Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294
- 2University of South Alabama College of Medicine, Mobile, AL 36688
- 3Medical Scientist Training Program, University of Florida, Gainesville, FL 32611
- 4RIKEN Center for Brain Science, Saitama 351-0198, Japan
- 5Department of Neurocognitive Science, Institute of Brain Science, Nagoya City University Graduates School of Medical Sciences, Nagaya 467-8601, Japan
- Correspondence should be addressed to Talene A. Yacoubian at tyacoubian{at}uabmc.edu.
Author contributions
Author contributions: M.G., E.D.R., and T.A.Y. designed research; M.G., B.W., S.A.S., S.Q., I.M., T.Sr., and A.C.R. performed research; T.S.a, T.C.S., and E.D.R. contributed unpublished reagents/analytic tools; M.G., B.W., S.A.S., S.Q., I.M., T.Sr., A.C.R., and T.A.Y. analyzed data; M.G. and T.A.Y. wrote the paper.
Disclosures
T.A.Y. has a United States Patent #7,919,262 on the use of 14-3-3s in neurodegeneration. All other authors declare no competing financial interests.
This work was supported by National Institutes of Health Grants R01 NS088533 and R01 NS112203 (to T.A.Y.), the Alzheimer’s of Central Alabama (T.A.Y.), and the University of Alabama at Birmingham School of Medicine AMC21 Multi-R01 Pilot Grant (to T.A.Y.).
Funding
HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
NS088533; NS112203Alzheimer’s of Central Alabama
University of Alabama at Birmingham School of Medicine
AMC21 Multi-R01 Pilot Grant
Other Version
- You are viewing the most recent version of this article.
- previous version (June 13, 2022).
Article usage
In this issue
14-3-3θ Does Not Protect against Behavioral or Pathological Deficits in Alzheimer’s Disease Mouse Models
